本研究针对氮芥诱导的角膜缘干细胞缺乏症（LSCD），开发出一种基于类脂蛋白纳米颗粒（HDL NP）的新型疗法，显著改善角膜混浊、减轻炎症反应，有望成为治疗 mustard keratopathy 及其他慢性角膜炎性疾病的有效手段。

New phase 3 data provide reassurance on safety, tolerability, and overall benefit-risk of mirvetuximab soravtansine (Elahere) ...

Aurion Biotech has launched its cell therapy Vyznova for serious eye disorder bullous keratopathy in Japan, its debut market, becoming an alternative to corneal replacement using donor tissue.

In addition to aniridia and neurotrophic keratopathy, RESTORE VISION is studying five other rare diseases affecting the ocular surface: ocular cicatricial pemphigoid, an autoimmune disease that ...

Aurion is developing AURN001, a clinical-stage allogeneic cell therapy asset, for corneal edema secondary to corneal ...